Check out: Top chart picks by market experts

Watch the interview of Hemen Kapadia of KR Choksey Securities who shared his readings and outlook on specific stocks and sector & Feroze Azeez of Anand Rathi Financial Services answered few personal finance queries.

Below is the verbatim transcript of Hemen Kapadia's interview with CNBC-TV18:Reliance Power Since listing Reliance Power has been in a downtrend and it posted lower tops and lower bottoms and in fact in August it posted fresh all time low, so things are not looking good. There is a lot of resistance around Rs 55. As of now it is a sell on bounce. We seem to be in a short-term uptrend which is threatening to convert into something even slightly better; sustainability at this point in time is very questionable looking at the past history. That doesn't mean it is never going to turn but it would be very difficult to rely on any positives we see on technical parameters. So at around Rs 55 is a level where one can consider exiting because I do not see otherwise for a long-term confirmation in terms of trend reversal will take a lot of time and you do not know whether it will sustain. The underperformance as of now doesn't seem to show anything except a bounce as of now.TBZ Tribhovandas Bhimji Zaveri (TBZ) posted fresh two year low at around Rs 110 and has been hovering around this range for the past three months including the current month. The difference is it bounced back in the current month, so entered a short-term uptrend which according to technical parameters is on the cusp of converting into medium-term uptrend. So as of now it is a hold. If the investor wants an aggressive stop loss, it should be at Rs 124. The safe stoploss should be Rs 110. So hold with a safe stoploss of Rs 110 for an aggressive stoploss of Rs 124.Pharma Stocks Most of the pharmaceutical stocks especially the quality ones have been in uptrend for the last five to six years, if not for a longer timeframe even Torrent Pharmaceuticals has done wonderful this year. The stock has appreciated from Rs 250 to Rs 1,700 - that's not the only criteria because we are in established longer term uptrend. We seem to have walked into an intermediate correction. The longer term outlook is positive but for safety, the investor can keep a stoploss of Rs 1,379 which is an intermediate bottom otherwise we are in a clear long-term uptrend and once it takes out Rs 1,700 all over again maybe it could take a few weeks or few months, we should continue this rally. In terms of midcap pharma stocks, Dishman Pharma looks technically interesting even Strides Arcolab but virtually every pharma stock has moved very sharply, so I would suggest Strides on slide decline.Tata Steel We have seen the BSE metal index and Tata Steel down to the last almost 16 months or so. We are in an established long-term downtrend, currently oversold, we are staging a recovery. We are not out of the woods yet, but one gets a feeling that a downward momentum is slowing down recently, time and price confirmation for that. I would suggest a hold only if one is a long-term investor. There could be pain, but recovery is foreseen after sometime. If one is not going to wait for so long, he/she needs to sell it on bounce.